Head and Neck Squamous Cell Carcinoma — Trials

Head and Neck Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,589 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 592
Recruiting: 314
Ph III recruiting: 31
Growth YoY: +30.1%
Industry share: 28%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (247)

clinicaltrialsPublishedShowing 351–357 of 357 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04807140	Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)	recruiting	Phase 2	57	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	1	Apr 14, 2023	clinicaltrials
NCT04992559	A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC	recruiting	Phase 2	41	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	1	Apr 14, 2023